Impaired Glucose Tolerance (IGT) Recruiting Phase 2 Trials for Liraglutide (DB06655)
Also known as: IGT - Impaired Glucose Tolerance / Intolerance to glucose / Impaired Glucose Tolerance (Prediabetes) / Glucose tolerance impaired / Impaired Glucose Tolerance / Glucose Intolerance / Decreased carbohydrate and glucose tolerance / Glucose tolerance decreased / Decreased glucose tolerance / Latent diabetes / Abnormal glucose NOS / Chemical diabetes
Indication | Status | Phase |
---|---|---|
DBCOND0042124 (Impaired Glucose Tolerance (IGT)) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02472717 | Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study | Treatment |